Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstanding growth potential.

We take our name, Apjohn, from the original family name of one of our founders. The use of this family name reflects our desire to inspire life sciences entrepreneurs to build pharmaceutical successes much like Dr. William E. Upjohn did at the turn of the last century.

We welcome you to our web site and invite you to learn more about Apjohn Ventures.
News

11.19..2009

Asterand Issues Interim Management Statement and Announces Agreement to Acquire BioSeek

11.09.2009

Ikano Therapeutics Receives Orphan Drug Designation for Epilepsy Drug

3.19.2008
ProNAi Cleared to Begin Phase I Clinical Trials

10.7.2005
Angiotech Completes Acquisition of Afmedica

 

Apjohn Ventures  :   269-349-8999  :   350 E. Michigan Avenue  :   Suite 500  :   Kalamazoo  :   Michigan  :   49007